Browse studies

Find your next paid study

27,333 recruiting studies available now

Libre Del Cigarrillo: Development of an mHealth Smoking Cessation App to Extend Reach of a Validated Smoking Cessation Intervention for Spanish-speaking Smokers

Pilot randomized controlled trial evaluating feasibility, acceptability, and trial-readiness of the new app compared with the existing print booklets and the N…

Smoking Cessation

Estimated

~$10 – $750

Actual pay is set by the research site.

H. Lee Moffitt Cancer Center and Research InstituteNCT07754448

Phase 1

NeuroFLiPP - Parametric PET of Neuroinflammation in Fatty Liver Disease

Alzheimer's Disease and related dementias (ADRD) affect about 6 million people in the U.S. and are the fifth leading cause of death for adults over 65. Recent …

Positron Emission Tomography

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of California, DavisNCT06453915

Observational

Resilient Together-ALS (RT-ALS): A Dyadic Mind-body Meaning Intervention for People With ALS and Their Informal Care-partners

The purpose of this study is to pilot a resiliency and coping intervention for persons recently diagnosed with Amyotrophic Lateral Sclerosis (ALS) and their pr…

Amyotrophic Lateral Sclerosis (ALS)Emotional Distress

Estimated

~$10 – $750

Actual pay is set by the research site.

Massachusetts General HospitalNCT06968468

Phase 1

Ruxolitinib-Enhanced Conditioning for Pediatric and Young Adult Patients With Symptomatic Sickle Cell Disease Undergoing Haploidentical Hematopoietic Cell Transplantation

This trial will determine whether adding ruxolitinib to a reduced intensity conditioning (RIC) regimen reduces the rate of graft failure following haploidentic…

Sickle Cell DiseaseHematopoetic Stem Cell TransplantHaploidentical Hematopoietic Stem Cell Transplant+2 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Arkansas Children's Hospital Research InstituteNCT07252050

Phase 2

Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease

This study is a randomized, double-blind, placebo-controlled trial specifically designed to evaluate the preliminary feasibility, initial efficacy and safety o…

Non-Alcoholic Fatty Liver Disease

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Justin RyderNCT06355310

Phase 1

First in Patient, Dose Escalation, Open Label Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous Infusion of BAY 3389934 to Patients With Sepsis Induced Coagulopathy

Researchers are looking for a better way to treat people who have sepsis induced coagulopathy. Sepsis happens when bacteria and their toxins spread in the blo…

SepsisCoagulopathy

Estimated

~$150 – $4,500

Actual pay is set by the research site.

BayerNCT06854640

Phase 1

A Randomized, Assessor-Blind, Parallel-Groups, Multicenter Trial Assessing the Safety and Efficacy, Including Pharmacokinetic Assessments, of CLENPIQ in Children Aged 12 Months to Less Than 9 Years

Bowel preparation for pediatric colonoscopy.

Bowel Preparation

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Ferring PharmaceuticalsNCT04113382

Baseline ACL Injury Risk Screening and Normative Data

This is a prospective, observational cohort study aimed at establishing a database of normative biomechanics for healthy athletes and surveying these athletes …

ACL InjuryAnterior Cruciate Ligament InjuriesMusculoskeletal Injury

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Sanford HealthNCT06635668

Observational

A Prospective, Randomized, Double-Blind, Placebo Controlled Clinical Study to Evaluate the Effects of KSM- 66 Ashwagandha® Capsule (300 mg) on Skin and Hair Health in Healthy Men and Women

Hair and skin play major roles in protecting the body, and maintaining their health is essential. Poor hair and skin health have become increasingly common due…

Skin HealthHair Health

Estimated

~$10 – $1,050

Actual pay is set by the research site.

SF Research Institute, Inc.NCT07215689

Phase 3

A Phase 3, Randomized, Open-Label, Multicenter Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)

Primary Objectives: To evaluate the safety (compared to iron sucrose) and efficacy of ferumoxytol in pediatric CKD subjects with iron deficiency anemia (IDA) …

Chronic Kidney Disease; Iron Deficiency Anemia

Estimated

~$50 – $2,100

Actual pay is set by the research site.

AMAG Pharmaceuticals, Inc.NCT03619850

Phase 2

Assessing Follow-Up Effects Post-Discontinuation of Hyperbaric Oxygen Therapy on Cognitive Function, Mental Health, and Quality of Life in Veterans

This study is designed to better understand the long-term effects of hyperbaric oxygen therapy (HBOT). Our goal is to determine whether improvements after trea…

Traumatic Brain InjuryPost-Concussive SymptomsPost-Traumatic Stress Disorder

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Summit Hyperbarics and WellnessNCT07732374

Natural History of Multiple Acyl-CoA Dehydrogenase Deficiency (MADD)

The objective of this study is to conduct a longitudinal, observational investigation to determine the natural history of Multiple Acyl-CoA Dehydrogenase Defic…

Multiple Acyl-CoA Dehydrogenase Deficiency

Estimated

~$10 – $750

Actual pay is set by the research site.

Icahn School of Medicine at Mount SinaiNCT07734090